NCT05548972View on ClinicalTrials.gov

G7 Dual Mobility With Vivacit-E or Longevity PMCF

NAEnrolling by invitationINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

January 31, 2037

Study Completion Date

August 31, 2037

Conditions
Hip OsteoarthritisRheumatoid ArthritisJoint DiseasesAvascular NecrosisDislocation, HipFemoral Neck FracturesTrochanteric FracturesRevision Surgeries
Interventions
DEVICE

G7 Dual Mobility with Vivacit-E bearing

hip arthroplasty with G7 Dual Mobility Vivacit-E bearing

DEVICE

G7 Dual Mobility Longevity bearing

hip arthroplasty with G7 Dual Mobility Longevity bearing

Trial Locations (10)

3000

UZ Leuven, Leuven

10021

Hospital for Special Surgery, New York

44195

The Cleveland Clinic, Cleveland

50612

Pusan National University Yangsan Hospital, Yangsan

58128

Chonnam National University Hwasun Hospital, Hwasun

72205

Bowen Hefley Orthopedics, Little Rock

80218

HCA HealthONE Orthopedic Specialists, Denver

97401

Slocum Research & Education Foundation, Eugene

07302

Jersey City Medical Center, Jersey City

Unknown

Istituto San Siro, Milan

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY